Placebo for Bempedoic Acid
Sponsors
Merck Sharp & Dohme LLC
Conditions
Hypercholesterolemia
Phase 3
A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn)
CompletedNCT06450366
Start: 2024-07-08End: 2025-03-28Updated: 2026-03-27
A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of MK-0616 Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia
CompletedCTIS2023-504920-25-00
Start: 2024-08-23End: 2025-02-27Target: 70Updated: 2025-02-20